
Telmikinz-H Tablet
Marketer
Henin Lukinz Pvt Ltd
Salt Composition
Telmisartan (40mg) + Hydrochlorothiazide (12.5mg)
Overview Telmikinz-H Tablet
Each Telmikinz-H Tablet combines two blood pressure-lowering medications, offering effective control when a single agent proves insufficient. This dual action reduces the long-term risk of stroke and heart attack. Telmikinz-H can be taken with or without food; dosage is personalized based on your response and health status. Consistent daily timing is recommended. Continue treatment as directed by your physician; discontinuation may increase cardiovascular risk. The formulation includes a diuretic, increasing urination, thus avoid late-evening doses (within four hours of bedtime). Consistent use is vital, even when feeling well, for optimal therapeutic benefit. High blood pressure is often asymptomatic. Common side effects include dizziness, fatigue, nausea, and dyspnea; palpitations may also occur. Increased urination is a intended therapeutic effect, not a side effect. While rare, other side effects are possible; consult the patient information leaflet and discuss any persistent or troubling effects with your doctor, who may adjust your dose or medication. Avoid potassium supplements or salt substitutes without your doctor's explicit approval. This medication is contraindicated during pregnancy and breastfeeding. Prior consultation is necessary if you have kidney or liver impairment, heart disease, or diabetes. Alcohol consumption may exacerbate blood pressure reduction and increase side effects.
Uses of Telmikinz-H Tablet
Managing elevated blood pressure
Major Benefits of Telmikinz-H Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the tablet whole; avoid crushing, chewing, or breaking it. Telmikinz-H Tablets can be taken with or without food, however, consistent timing is recommended.
Common Side effects of Telmikinz-H Tablet:
- Fatigue
- Dizziness
- Nausea
- Decreased magnesium level in blood
How to use Telmikinz-H Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Telmikinz-H Tablets can be taken with or without food, however, consistent timing is recommended.
How Telmikinz-H Tablet works:
Telmikinz-H tablets contain a dual-drug formulation.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Telmikinz-H Tablet lacks established safety data. Physician consultation is advised.
PregnancyCONSULT YOUR DOCTOR
Using Telmikinz-H tablets during pregnancy poses a confirmed risk to the fetus. Therefore, it's contraindicated. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Always seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Using Telmikinz-H tablets while breastfeeding is likely inadvisable. Studies in humans indicate a potential for the medication to transfer to breast milk, posing a risk to the infant.
DrivingUNSAFE
Driving may be unsafe while taking Telmikinz-H Tablets due to potential side effects including drowsiness, blurred vision, and dizziness. Avoid operating a vehicle if you experience these effects.
KidneyCAUTION
Patients with severe kidney impairment should exercise caution when using Telmikinz-H tablets, potentially requiring dosage modification under medical supervision. Telmikinz-H tablets are contraindicated in patients with severe renal dysfunction.
LiverCAUTION
Patients with liver impairment should use Telmikinz-H Tablets cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Telmikinz-H Tablet :
Should you forget a Telmikinz-H Tablet dose, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Telmikinz-H Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | HEART |
